Compugen teams with Johns Hopkins University on immune checkpoints
Collaboration to assist Israeli drug discovery company in further substantiating potential of its novel proteins as targets for cancer immunotherapy.
Collaboration to assist Israeli drug discovery company in further substantiating potential of its novel proteins as targets for cancer immunotherapy.
ISRAEL21c rounds up the top super-cool technological advances from Israeli companies that you should keep an eye on next year.
The agreement is for the research, development and commercialization of antibody-based therapeutics for cancer immunotherapy.